Amresh Raina, MD
Basic profileAmresh Raina is a Cardiology physician affiliated with Allegheny Health Network. OpenAlex indexes 174 publications with 3,346 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck & Co.Program year20255 paymentsResearch$132,049
- United TherapeuticsProgram year202515 paymentsResearch$20,892
- JanssenProgram year202518 paymentsResearch$15,913
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.9%Loop diuretic11.2%Bumetanide54%Furosemide34%Torsemide12%Part D<11 patientsBeta blocker11.2%Carvedilol50%Metoprolol Succinate43%Metoprolol Tartrate8%Part D<11 patients+ 17 more classes in this area
Blood & clotting
10%Factor Xa inhibitor4%Eliquis100%Part D≥26 patientsProstacyclin Receptor Agonist2.3%Uptravi100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
8.9%Proton pump inhibitor3.5%Pantoprazole Sodium57%Omeprazole43%Part D<11 patientsPotassium supplement2.4%Potassium Chloride80%Klor-Con M2020%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
European Respiratory Journal
2024 - Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Kalathil Sureshkumar, MD
Allegheny Health Network
Susan Manzi, MD
Allegheny Health Network
Nathan Bahary, MD, PhD
Allegheny Health Network
Blair Jobe, MD
Allegheny Health Network
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”